Oxford Nanopore Technologies promethION Flow Cells
Closed Pre-Solicitation Posted
- Solicitation number
- 75N98026Q00698
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541713 Research and Development in Nanotechnology
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH) Office of the Director intends to award a contract without full and open competition to Oxford Nanopore Technologies Inc for promethION Flow Cells, with a response deadline of July 6, 2026. This is a sole-source procurement under FAR Part 13 Simplified Acquisition Procedures, not subject to competition requirements. The estimated contract value does not exceed the simplified acquisition threshold of $350,000. The procurement is classified under NAICS code 541713 (Research and Development in Nanotechnology), with a small business size standard of $1,000. NIH requests 22 packs of the flow cells. The contracting office is NIH's Office of Acquisition and Logistics Management, Hospital and Laboratory Support Division, located at 6701 Rockledge Drive, Bethesda, Maryland 20817. The contract will incorporate all applicable FAR provisions through FAC 2026-01 (March 13, 2026).
Notice text
General Information
Document Type:
Presolicitation
Synopsis Number:
75N98026Q00698
Posted Date:
June 24, 2026
Original Response Date:
July 6, 2026
Current Response Date:
July 6, 2026
Set Aside:
N/A
NAICS Code:
541713
Contracting Office Address
National Institutes of Health (NIH), Office of the Director (OD)
Office of Logistics and Operations (OLAO)
Office of Acquisition and Logistics Management (OALM)
Hospital and Laboratory Support Division
6701 Rockledge Drive
Bethesda, MD 20817
Description
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:
Oxford Nanopore Technologies Inc
101 Avenue of the Americas
New York 10013
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 541713 with a Size Standard $1000.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
GENERAL INFORMATION
- Title: Oxford Nanopore Technologies promethION Flow Cells
- Background Information: We are requesting 22 packs of ONT promethION flow cells (11 for DNA and 11 for RNA), with 4 flow cells per pack, which are required to carry out long-read sequencing of experimental sample tissues on our oxford nanopore sequencer.
CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
All responses must be received by July 6, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00698. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.
"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NOI - 4D-Nucleofector Core Unit and X Unit | Office of Logisitics and Acquisition Operations | No set-aside | |
| RNA sequencing and whole genome sequencing services | Office of Logisitics and Acquisition Operations | No set-aside | |
| 1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) | National Institute of Allergy and Infectious Diseases | No set-aside | |
| NCSS - Bioruptor Pico Sonication Device | Office of Logisitics and Acquisition Operations | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity